Journal of Gastrointestinal Surgery

, Volume 13, Issue 3, pp 486–491 | Cite as

Radiofrequency Ablation vs. Resection for Hepatic Colorectal Metastasis: Therapeutically Equivalent?

  • Nathaniel P. Reuter
  • Charles E. Woodall
  • Charles R. Scoggins
  • Kelly M. McMasters
  • Robert C. G. Martin
original article



The role of ablation for hepatic colorectal metastases (HCM) continues to evolve as ablation technology changes and systemic chemotherapy improves. Our aim was to evaluate the therapeutic efficacy of radiofrequency ablation (RFA) of HCM compared to surgical resection.


A retrospective review of our 1,105 patient prospective hepatic database from August 1995 to July 2007 identified 192 patients with only hepatic resection or only ablation for HCM.


Patients who underwent RFA were similar to resection patients based on a similar Fong score (1.8 vs. 2.1 p = 0.28), presence of extrahepatic disease (15% vs. 9% p = 0.19), mean number of hepatic lesions (2.8 vs. 2.1 p = 0.14), and prior chemotherapy (67% vs. 60% p = 0.33). Median time to recurrence was shorter with ablation than resection (12.2 vs. 31.1 months; p < 0.001). Recurrence at the ablation–resection site was more common with ablation than resection occurring 17% vs. 2% (p ≤ 0.001) of the time, respectively. Distant recurrence in the liver was also more common with ablation occurring in 33% of patients vs. 14% for resection (p = 0.002).


Surgical resection is associated with a lower chance of recurrence and a longer disease-free interval than RFA and should remain the treatment of choice in resectable HCM.


Radio frequency ablation Hepatic resection Colorectal liver metastasis 


  1. 1.
    Sjovall A, Jarv V, Blomqvist L, Singnomklao T, Cedermark B, Glimelius B, et al. The potential for improved outcome in patients with hepatic metastases from colon cancer: a population-based study. Eur J Surg Oncol 2004;30:834–841. doi:10.1016/j.ejso.2004.06.010.PubMedCrossRefGoogle Scholar
  2. 2.
    Nicholl MB, Bilchik AJ. Thermal ablation of hepatic malignancy: useful but still not optimal. Eur J Surg Oncol 2008;34:318–323. doi:10.1016/j.ejso.2007.07.203.PubMedGoogle Scholar
  3. 3.
    Couinaud C. Le Foi: Etudes Anatomogiques et Chirugicales. Paris: Masson, 1957.Google Scholar
  4. 4.
    Martin RC, Edwards MJ, McMasters KM. Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver. Am J Surg 2004;188:714–721. doi:10.1016/j.amjsurg.2004.08.042.PubMedCrossRefGoogle Scholar
  5. 5.
    Martin RC, Scoggins CR, McMasters KM. Microwave hepatic ablation: initial experience of safety and efficacy. J Surg Oncol 2007;96:481–486. doi:10.1002/jso.20750.PubMedCrossRefGoogle Scholar
  6. 6.
    Martin R, Paty P, Fong Y, Grace A, Cohen A, DeMatteo R, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 2003;197:233–241. doi:10.1016/S1072-7515(03)00390-9.PubMedCrossRefGoogle Scholar
  7. 7.
    Curley SA, Izzo F, Delrio P, Ellis LM, Granchi J, Vallone P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999;230:1–8. doi:10.1097/00000658-199907000-00001.PubMedCrossRefGoogle Scholar
  8. 8.
    Wong SL, Edwards MJ, Chao C, Simpson D, McMasters KM. Radiofrequency ablation for unresectable hepatic tumors. Am J Surg 2001;182:552–557. doi:10.1016/S0002-9610(01)00813-3.PubMedCrossRefGoogle Scholar
  9. 9.
    Oshowo A, Gillams A, Harrison E, Lees WR, Taylor I. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg 2003;90:1240–1243. doi:10.1002/bjs.4264.PubMedCrossRefGoogle Scholar
  10. 10.
    Aloia TA, Vauthey JN, Loyer EM, Ribero D, Pawlik TM, Wei SH, et al. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 2006;141:460–466. doi:10.1001/archsurg.141.5.460.PubMedCrossRefGoogle Scholar
  11. 11.
    Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004;239:818–825. doi:10.1097/01.sla.0000128305.90650.71.PubMedCrossRefGoogle Scholar
  12. 12.
    Gillams AR, Lees WR. Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 2004;14:2261–2267. doi:10.1007/s00330-004-2416-z.PubMedCrossRefGoogle Scholar
  13. 13.
    Machi J, Oishi AJ, Sumida K, Sakamoto K, Furumoto NL, Oishi RH, et al. Long-term outcome of radiofrequency ablation for unresectable liver metastases from colorectal cancer: evaluation of prognostic factors and effectiveness in first- and second-line management. Cancer J 2006;12:318–326. doi:10.1097/00130404-200607000-00011.PubMedCrossRefGoogle Scholar
  14. 14.
    Abitabile P, Hartl U, Lange J, Maurer CA. Radiofrequency ablation permits an effective treatment for colorectal liver metastasis. Eur J Surg Oncol 2007;33:67–71. doi:10.1016/j.ejso.2006.10.040.PubMedGoogle Scholar
  15. 15.
    Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005;241:715–722. doi:10.1097/01.sla.0000160703.75808.7d, discussion.PubMedCrossRefGoogle Scholar
  16. 16.
    Livraghi T, Solbiati L, Meloni F, Ierace T, Goldberg SN, Gazelle GS. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the “test-of-time approach”. Cancer 2003;97:3027–3035. doi:10.1002/cncr.11426.PubMedCrossRefGoogle Scholar
  17. 17.
    van Duijnhoven FH, Jansen MC, Junggeburt JM, van Hillegersberg R, Rijken AM, van Coevorden F, van dS Jr, et al. Factors influencing the local failure rate of radiofrequency ablation of colorectal liver metastases. Ann Surg Oncol 2006;13:651–658. doi:10.1245/ASO.2006.08.014.PubMedCrossRefGoogle Scholar
  18. 18.
    Wood TF, Rose DM, Chung M, Allegra DP, Foshag LJ, Bilchik AJ. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 2000;7:593–600.PubMedGoogle Scholar
  19. 19.
    Kokudo N, Miki Y, Sugai S, Yanagisawa A, Kato Y, Sakamoto Y, et al. Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection. Arch Surg 2002;137:833–840. doi:10.1001/archsurg.137.7.833.PubMedCrossRefGoogle Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2008

Authors and Affiliations

  • Nathaniel P. Reuter
    • 1
  • Charles E. Woodall
    • 1
  • Charles R. Scoggins
    • 1
  • Kelly M. McMasters
    • 1
  • Robert C. G. Martin
    • 1
  1. 1.Division of Surgical Oncology, Department of SurgeryUniversity of Louisville School of MedicineLouisvilleUSA

Personalised recommendations